Background Breast cancer care has been affected by the COVID-19 pandemic. This
systematic review aims to describe the observed pandemic-related changes in clinical and …

Objective The ongoing COVID-19 pandemic has caused an indefinite delay to cancer
screening programs worldwide. This study aims to explore the impact on breast cancer …

Please see the Editorial Comment by Olga R. Brook discussing this article. An unanticipated
but severe shortage in iodinated contrast media (ICM) is currently affecting imaging …

Importance Several studies reported sharp decreases in screening mammography for breast
cancer and low-dose computed tomographic screening for lung cancer in the early months …

As a way of slowing COVID-19 transmission, many countries and US states implemented
shelter-in-place (SIP) policies. However, the effects of SIP policies on public health are a …

Purpose The early months of the COVID-19 pandemic led to reduced cancer screenings and
delayed cancer surgeries. We used insurance claims data to understand how breast cancer …

Abstract On July 29, 2021, the US Food and Drug Administration's Oncology Center of
Excellence convened Conversations on Cancer. This Conversation, the first ever by the US …

Simple Summary The COVID-19 pandemic has had a significant impact on health care
including cancer screening. We examined 2020 compared to the 2014–2019 cancer …

OBJECTIVES The coronavirus disease 2019 (COVID-19) pandemic has affected the
utilization of healthcare services, including participation in cancer screening programs. We …

The COVID-19 pandemic created unprecedented disruptions to routine health care in the
United States. Screening mammography, a cornerstone of breast cancer control and …